Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL7600510 | 0.83 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL248760 | 0.78 | CTSD (0.33) | — | |
| Bromide SCHEMBL7870148 | 0.76 | CTSD (0.32) | — | |
| Hydrochloric Acid SCHEMBL137722 | 0.76 | CTSD (0.32) | — | |
| Hydrochloric Acid SCHEMBL4093025 | 0.76 | CTSD (0.32) | — | |
| Butane SCHEMBL8165611 | 0.74 | — | — | |
| SCHEMBL8652405 | 0.74 | CTSD (0.31) | — | |
| Chloromethane SCHEMBL3682470 | 0.74 | CTSD (0.31) | — | |
| SCHEMBL2191663 | 0.72 | — | — | |
| Water SCHEMBL2780320 | 0.68 | ALDH1A1 (0.65) | MAOAMAOBKCNH2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7332551-B2 | Partially fluorinated naphthyl-based borates | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-7077977-B2 | Bulky borate activations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-07-18 | — | — | US | disclosed |
| US-6909008-B2 | Cocatalyst compositions | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-06-21 | — | — | US | disclosed |
| US-20050049436-A1 | Partially fluorinated naphthyl-based borates | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-03-03 | — | — | US | disclosed |
| EP-1509552-A1 | SOLID, PARTICULATED, SPRAY DRIED, HETEROGENOUS CATALYST COMPOSITION | Univation Technologies LLC (US) | 2005-03-02 | — | — | EP | disclosed |
| US-20040254065-A1 | Bulky borate activations | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-16 | — | — | US | disclosed |
| US-20040199021-A1 | DICOPS CONTAINING ACETYLENIC SUBSTITUENTS | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-10-07 | — | — | US | disclosed |
| EP-1463738-A1 | PARTIALLY FLUORINATED NAPHTHYL-BASED BORATES | Exxonmobil Chemical Patents Inc. (US) | 2004-10-06 | — | — | EP | disclosed |
| US-20040152591-A1 | Polymerized metallocene catalyst composition | EXXONMOBIL CHEMICAL PATENTS, INC. | 2004-08-05 | — | — | US | disclosed |
| WO-2003102037-A1 | SOLID, PARTICULATED, SPRAY DRIED, HETEROGENOUS CATALYST COMPOSITION | UNIVATION TECHNOLOGIES, LLC (US) | 2003-12-11 | — | — | WO | disclosed |
| WO-2002088197-A2 | SOLUTION POLYMERIZATION PROCESS WITH DISPERSED CATALYST ACTIVATOR | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-11-07 | — | — | WO | disclosed |
| US-5883204-A | ADDING AN IONIC CATALYST ACTIVATOR TO A SOLUTION OLEFIN POLYMERIZATION REACTION | THE DOW CHEMICAL COMPANY (US) | 1999-03-16 | — | — | US | disclosed |
| EP-0889910-A1 | SOLUTION POLYMERIZATION PROCESS WITH DISPERSED CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1999-01-13 | — | — | EP | disclosed |
| EP-0591756-B1 | Polymerization catalysts and process for producing polymers | IDEMITSU KOSAN CO (JP) | 1998-11-25 | — | — | EP | disclosed |
| EP-0522581-B1 | Process for producing olefin based polymers and olefin polymerization catalyst | IDEMITSU KOSAN CO (JP) | 1997-10-15 | — | — | EP | disclosed |
| WO-1997035892-A1 | SOLUTION POLYMERIZATION PROCESS WITH DISPERSED CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1997-10-02 | — | — | WO | disclosed |
| US-5461127-A | Comprising group 4 metal, cyclic hydrocarbon, ligands, Lewis base; addition polymerization | IDEMITSU KOSAN CO., LTD. (JP) | 1995-10-24 | — | — | US | disclosed |
| US-5444134-A | Using a coordination catalyst | IDEMITSU KOSAN CO., LTD. (JP) | 1995-08-22 | — | — | US | disclosed |
| EP-0591756-A2 | Polymerization catalysts and process for producing polymers | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-04-13 | — | — | EP | disclosed |
| EP-0522581-A1 | Process for producing olefin based polymers and olefin polymerization catalyst | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040199021-A1 | DICOPS CONTAINING ACETYLENIC SUBSTITUENTS | AADAC, NAA15, ALG8 | CYP1A2 2551/4885CYP2D6 2571/4885CYP2C19 3805/4885 |
| US-20050049436-A1 | Partially fluorinated naphthyl-based borates | NBAS, TNK1, POF1B | CYP1A2 3725/4885CYP2D6 3380/4885CYP2C19 3006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.